{"id":"W6927423988","doi":"10.3205/18dgrh176","title":"5 years of Secukinumab – high sustained efficacy and favorable safety in psoriasis patients with psoriatic arthritis at baseline","year":2019,"lang":"en","type":"article","venue":"German Medical Science (German Research Foundation)","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"XLV Diagnostics (Canada); Probity Medical Research; Innovaderm (Canada)","funders":"","keywords":"Secukinumab; Psoriatic arthritis; Psoriasis; Monoclonal antibody; Arthritis; Adverse effect; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003850278,0.0001694103,0.0003775987,0.0005438384,0.0003725881,0.0000421968,0.000485214,0.0001751828,0.004121823],"category_scores_gemma":[0.001021422,0.000140269,0.00004026559,0.001327136,0.001501026,0.0003886025,0.0003251831,0.0003479549,0.0007436919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003028985,"about_ca_system_score_gemma":0.0006627341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002842642,"about_ca_topic_score_gemma":0.0003012649,"domain_scores_codex":[0.9966964,0.0005614166,0.0004656929,0.0006041119,0.0008561764,0.0008161914],"domain_scores_gemma":[0.9980235,0.0008730283,0.0001247468,0.0004319411,0.0003741891,0.0001725846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002356735,0.001169514,0.09095649,0.0001273844,0.00016687,0.00006570404,0.002087131,0.000009342967,0.004671657,0.007592271,0.0004228562,0.8903741],"study_design_scores_gemma":[0.01745817,0.000975673,0.9685192,0.0002988311,0.00003064645,0.00001957357,0.0001958343,0.00008927689,0.002250773,0.0006040287,0.009213062,0.0003448926],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997912,0.0001984088,0.00001936251,0.000388564,0.0003213453,0.0007149366,0.0000239679,0.00002416857,0.0003971805],"genre_scores_gemma":[0.9982937,0.0002836962,0.00009400413,0.00004500053,0.00003465952,0.00003026713,0.0002949518,0.00001397928,0.0009097328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8900291,"threshold_uncertainty_score":0.9967886,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01314409996503122,"score_gpt":0.3024600288708942,"score_spread":0.289315928905863,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}